Trials / Not Yet Recruiting
Not Yet RecruitingNCT06293430
Registry on Luma Vision's VERAFEYE System (ENLIgHT)
Registry on Luma Vision's VERAFEYE System in Catheter Ablation and Left Atrial Appendage Closure Procedures
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- LUMA Vision Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to compile real-world data on the use of the VERAFEYE System in standard of care atrial fibrillation (AF) ablation procedures and left atrial appendage closure (LAAC) procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VERAFEYE System | VERAFEYE system guidance will be used on all patients undergoing AF ablation and/or LAAC procedures. |
Timeline
- Start date
- 2026-11-15
- Primary completion
- 2027-07-15
- Completion
- 2027-07-15
- First posted
- 2024-03-05
- Last updated
- 2026-04-14
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06293430. Inclusion in this directory is not an endorsement.